Enzalutamide’s Added Benefits in Prostate Cancer Patients Revealed

Enzalutamide’s Added Benefits in Prostate Cancer Patients Revealed
Enzalutamide (Xtandi) has been proven effective in prolonging the overall survival of patients suffering from prostate cancer, while decreasing the probability of disease complications, when compared with watchful waiting, by the German Institute for Quality and Efficiency in Health Care (IQWiG). The study conducted in men older than 75 years revealed the added value of the drug. The new

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *